Linda Yaccarino joins health tech platform eMed as CEO after leaving X

Linda Yackerino’s next introduction Departure X will play another chief executive role as CEO EMED population healthAn AI startup creates a technology platform for patients using GLP -1S.

Yackerino had a long -time advertising executive at NBC Universal but kept joining X as a CEO for two years, where he was able to achieve an achievement Positive influence In the model of earning unstable advertising on social networks, despite the Elon mask shared by Elon Mask to reduce the addition of wire and content.

Although Yackerino has no experience in health technology, Emede said in a press release that they wanted him for his “new partnership negotiating skills”-it certainly helped his tenure to be well known in the technology world, drawing more eyes.

Medal Before A technology has created a platform that was designed to use A -Home Covid -10 Rapid antigen tests, guiding users through the proper management process. Now the AMED has been focused on GLP -1S, the class of drugs like ozampic, which can be used for both type 2 diabetes weight management and treatment.

“To be a leader in today’s healthcare marketplace, a fearless view of the organization needs to have ACity that they can not only grow, but can be brave enough to define the whole industry and newly,” Yackerino D In a press release. “We are in a very good position as that strict leader, looking at our ultimate goal of improving global healthcare results through our groundbreaking services and platforms.”